Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
2 Acute myeloid leukemia 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
3 Alcoholism 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
4 Alcoholism 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
5 Alzheimer disease 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
6 Alzheimer disease 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
7 Apelin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
8 Apelin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
9 Apoptosis 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
10 Apoptosis 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
11 Autophagy - animal 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
12 Autophagy - animal 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
13 Axon guidance 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
14 Axon guidance 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
15 B cell receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
16 B cell receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
17 Bladder cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
18 Bladder cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
19 Breast cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
20 Breast cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
21 C-type lectin receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
22 C-type lectin receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
23 Cadherin signaling 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
24 Cadherin signaling 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
25 cAMP signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
26 cAMP signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
27 Cellular senescence 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
28 Cellular senescence 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
29 Central carbon metabolism in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
30 Central carbon metabolism in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
31 cGMP-PKG signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
32 cGMP-PKG signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
33 Chemical carcinogenesis - reactive oxygen species 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
34 Chemical carcinogenesis - reactive oxygen species 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
35 Chemical carcinogenesis - receptor activation 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
36 Chemical carcinogenesis - receptor activation 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
37 Chemokine signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
38 Chemokine signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
39 Choline metabolism in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
40 Choline metabolism in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
41 Chronic myeloid leukemia 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
42 Chronic myeloid leukemia 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
43 Colorectal cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
44 Colorectal cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
45 Endometrial cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
46 Endometrial cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
47 ErbB signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
48 ErbB signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
49 Estrogen signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
50 Estrogen signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
51 Fc epsilon RI signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
52 Fc epsilon RI signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
53 Fc gamma R-mediated phagosome formation 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
54 Fc gamma R-mediated phagosome formation 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
55 Focal adhesion 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
56 Focal adhesion 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
57 FoxO signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
58 FoxO signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
59 Gap junction 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
60 Gap junction 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
61 Gastric cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
62 Gastric cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
63 Glioma 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
64 Glioma 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
65 GnRH secretion 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
66 GnRH secretion 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
67 GnRH signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
68 GnRH signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
69 Growth hormone synthesis, secretion and action 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
70 Growth hormone synthesis, secretion and action 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
71 Hepatitis B 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
72 Hepatitis B 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
73 Hepatitis C 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
74 Hepatitis C 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
75 Hepatocellular carcinoma 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
76 Hepatocellular carcinoma 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
77 Human cytomegalovirus infection 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
78 Human cytomegalovirus infection 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
79 Human immunodeficiency virus 1 infection 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
80 Human immunodeficiency virus 1 infection 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
81 Human papillomavirus infection 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
82 Human papillomavirus infection 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
83 Influenza A 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
84 Influenza A 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
85 Insulin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
86 Insulin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
87 JAK-STAT signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
88 JAK-STAT signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
89 Kaposi sarcoma-associated herpesvirus infection 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
90 Kaposi sarcoma-associated herpesvirus infection 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
91 Long-term depression 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
92 Long-term depression 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
93 Long-term potentiation 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
94 Long-term potentiation 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
95 MAPK signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
96 MAPK signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
97 Melanogenesis 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
98 Melanogenesis 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
99 Melanoma 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
100 Melanoma 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
101 MicroRNAs in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
102 MicroRNAs in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
103 mTOR signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
104 mTOR signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
105 Natural killer cell mediated cytotoxicity 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
106 Natural killer cell mediated cytotoxicity 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
107 Neurotrophin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
108 Neurotrophin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
109 Neutrophil extracellular trap formation 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
110 Neutrophil extracellular trap formation 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
111 Non-small cell lung cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
112 Non-small cell lung cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
113 Oxytocin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
114 Oxytocin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
115 Pancreatic cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
116 Pancreatic cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
117 Parathyroid hormone synthesis, secretion and action 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
118 Parathyroid hormone synthesis, secretion and action 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
119 Pathways in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
120 Pathways in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
121 Pathways of neurodegeneration - multiple diseases 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
122 Pathways of neurodegeneration - multiple diseases 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
123 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
124 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
125 Phospholipase D signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
126 Phospholipase D signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
127 PI3K-Akt signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
128 PI3K-Akt signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
129 Progesterone-mediated oocyte maturation 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
130 Progesterone-mediated oocyte maturation 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
131 Prolactin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
132 Prolactin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
133 Prostate cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
134 Prostate cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
135 Proteoglycans in cancer 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
136 Proteoglycans in cancer 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
137 Rap1 signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
138 Rap1 signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
139 Ras signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
140 Ras signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
141 Regulation of actin cytoskeleton 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
142 Regulation of actin cytoskeleton 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
143 Relaxin signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
144 Relaxin signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
145 Renal cell carcinoma 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
146 Renal cell carcinoma 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
147 Salmonella infection 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
148 Salmonella infection 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
149 Serotonergic synapse 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
150 Serotonergic synapse 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
151 Signaling pathways regulating pluripotency of stem cells 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
152 Signaling pathways regulating pluripotency of stem cells 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
153 Sphingolipid signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
154 Sphingolipid signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
155 T cell receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
156 T cell receptor signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
157 Thyroid hormone signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
158 Thyroid hormone signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
159 Tuberculosis 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
160 Tuberculosis 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
161 Vascular smooth muscle contraction 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
162 Vascular smooth muscle contraction 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬
163 VEGF signaling pathway 💬
[1] RAF1 💬 Sorafenib tosylate 💬 Sorafenib [2] 34, 86 💬
164 VEGF signaling pathway 💬
[1] RAF1 💬 Sorafenib 💬 Sorafenib [2] 34, 86 💬